This study is a prospective cohort dedicated to pancreatic diseases excluding cancer. The aim is to develop positive or differential diagnostic tools between benign potentially malignant or malignant pancreatic pathologies. During this study the investigators collect data and biological samples to support research project.
This collection focuses on pathology of the pancreas requiring specific investigations or management for diagnosis or treatment. Pancreatic pathologies can be classified as malignant, potentially malignant or benign tumors. These can be solid or cystic. There is an inflammatory attack on the pancreas, generating acute pancreatitis in the acute period, if the inflammatory manifestations persist, chronic pancreatitis will develop. Some lesions may be at risk of malignancy during their evolution, it is therefore necessary to improve the performance of monitoring and diagnostic tools in order to adapt the management of patients.
Study Type
OBSERVATIONAL
Enrollment
300
Rangueil hospital
Toulouse, France
RECRUITINGDiagnostic tools
To develop positive or differential diagnostic tools between benign potentially malignant or malignant pancreatic pathologies
Time frame: 3 years after the first inclusion
New targets
To identify new screening targets
Time frame: 3 years after the first inclusion
Improvement of management
To improve the management of cystic lesions or Chronic pancreatitis on the decision of therapeutic management
Time frame: 3 years after the first inclusion
Microbiota
Study of the microbiota of pancreatic diseases
Time frame: 3 years after the first inclusion
Clinical data access
To make available to the scientific community quality material with associated clinical data also of quality
Time frame: 3 years after the first inclusion
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.